Aristotle Capital Boston, LLC, an investment advisor, released its fourth-quarter investor letter for “Small Cap Equity Fund”. A copy of the letter can be downloaded here. U.S. small-cap equities reported modest gains in the fourth quarter of 2025. The quarter started as a continuation of the post-Liberation Day risk-on market environment, while it ended on a strong note, driven by a positive macroeconomic backdrop. Attractive valuations, earnings recovery, broadening of the market, and a shift from mega-cap stocks supported small caps in the quarter. The Aristotle Small Cap Equity Fund (Class I-2) returned 1.96% in Q4 2025, trailing the 2.19% total return of the Russell 2000 Index. Security selection supported overall performance, while allocation effects detracted from performance. Please review the Strategy’s top five holdings to gain insights into their key selections for 2025.
In its fourth-quarter 2025 investor letter, Aristotle Small Cap Equity Fund featured stocks like Nu Skin Enterprises, Inc. (NYSE:NUS). Headquartered in Provo, Utah, Nu Skin Enterprises, Inc. (NYSE:NUS) is a wellness and beauty care company. On February 13, 2026, Nu Skin Enterprises, Inc. (NYSE:NUS) stock closed at $8.36 per share. One-month return of Nu Skin Enterprises, Inc. (NYSE:NUS) was -27.56%, and its shares are up 10.58% over the past twelve months. Nu Skin Enterprises, Inc. (NYSE:NUS) has a market capitalization of $407.55 million.
Aristotle Small Cap Equity Fund stated the following regarding Nu Skin Enterprises, Inc. (NYSE:NUS) in its fourth quarter 2025 investor letter:
“Nu Skin Enterprises, Inc. (NYSE:NUS) is a developer and distributor of beauty and wellness solutions. The position was liquidated due to deteriorated fundamental performance and an ongoing strategic transformation with an uncertain fundamental outlook.”
Nu Skin Enterprises, Inc. (NYSE:NUS) is not on our list of 30 Most Popular Stocks Among Hedge Funds. According to our database, 20 hedge fund portfolios held Nu Skin Enterprises, Inc. (NYSE:NUS) at the end of the third quarter, the same as in the previous quarter. While we acknowledge the potential of Nu Skin Enterprises, Inc. (NYSE:NUS) as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
In addition, please check out our hedge fund investor letters Q4 2025 page for more investor letters from hedge funds and other leading investors.
